Novagali Pharma
Latest round
- Series D
Last raised
- Dec 2008
Total raised
- $43M
Investors
- 7
About Novagali Pharma
Novagali Pharma SA specializes in ophthalmic products, with its headquarters located in France.00 mn. In October 2011, Novagali Pharma was acquired by Santen Pharmaceutical.Novagali Pharma SA develops a range of eye care solutions, focusing on treatments for various ocular conditions.Moving forward, Novagali Pharma SA is focused on launching new ophthalmic products designed to address unmet medical needs. The successful completion of its IPO in July 2010 for EUR 22 mn will facilitate these strategic initiatives.
Who invested in Novagali Pharma
7 investors across 4 rounds
See all investors in Novagali Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Novagali Pharma
Who invested in Novagali Pharma?
Novagali Pharma has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novagali Pharma raised?
Novagali Pharma has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Novagali Pharma last raise money?
Novagali Pharma's most recent round on record is a Series D, in Dec 2008.
What does Novagali Pharma do?
Novagali Pharma SA specializes in ophthalmic products, with its headquarters located in France.
Where is Novagali Pharma headquartered?
Novagali Pharma is headquartered in France.
Which VCs invest in companies like Novagali Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Novagali Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Novagali Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.